Showing results (11-20 of 80) with videos related to
Sort By:
Pageof 8
British Journal of Clinical Pharmacology|January 21, 2022
Hypokalaemia in patients treated with intravenous flucloxacillin: Incidence and risk factorsEmiel Leegwater, Annette C Westgeest, Emile F Schippers, et al.The Journal of Antimicrobial Chemotherapy|April 11, 2023
Drug-drug interaction: decreased posaconazole trough concentrations during concomitant flucloxacillin treatmentJulia M Wortman, Emiel Leegwater, Daniëlle Van Lammeren-Venema, et al.International Journal of Clinical Pharmacy|November 28, 2018
The impact of an infectious disease expert team on outpatient parenteral antimicrobial treatment in the NetherlandsRoos Wijnakker, Loes E Visser, Emile F Schippers, et al.BMJ Case Reports|June 8, 2012
Overwhelming primary Epstein-Barr virus infection requiring corticosteroid treatmentMarije Gordinou de Gouberville, Martien Janssen, Anita Schrander-van der Meer, et al.The Journal of Urology|October 15, 2018
Intravesical Gentamicin Treatment for Recurrent Urinary Tract Infections Caused by Multidrug Resistant BacteriaJanneke E Stalenhoef, Cees van Nieuwkoop, Petra H Menken, et al.The Journal of Emergency Medicine|September 24, 2016
Appendicitis Presenting As Cellulitis of the Right LegLeonie T van Hulsteijn, J Sven D Mieog, Maarten H T Zwartbol, et al.The Journal of Antimicrobial Chemotherapy|July 27, 2020
Pharmacokinetics of fosfomycin in patients with prophylactic treatment for recurrent Escherichia coli urinary tract infectionSander G Kuiper, Anneke C Dijkmans, Erik B Wilms, et al.Nederlands Tijdschrift Voor Geneeskunde|September 4, 2025
[Challenges concerning lymphadenopathy after COVID-19 vaccination]Linda Davidson, Cees van Nieuwkoop, Tamara N Platteel, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 29, 2020
Drug-induced Liver Injury in a Patient With Coronavirus Disease 2019: Potential Interaction of Remdesivir With P-Glycoprotein InhibitorsEmiel Leegwater, Anne Strik, Erik B Wilms, et al.BMC Infectious Diseases|December 7, 2018
Oral fosfomycin versus ciprofloxacin in women with E.coli febrile urinary tract infection, a double-blind placebo-controlled randomized controlled non-inferiority trial (FORECAST)Thijs Ten Doesschate, Suzan P van Mens, Cees van Nieuwkoop, et al.Pageof 8